T. Rowe Price Mid Cap Growth Portfolio BIIB Holdings History
T. Rowe Price Mid Cap Growth Portfolio's Biogen Inc Holding Summary
As of 2025-03-31, Brighthouse Funds Trust I held 7,056.00 shares of Biogen Inc(BIIB), totaling $652,680.00. This investment constitutes 0.06% of their stock portfolio, and Brighthouse Funds Trust I now holds 0% of the outstanding Biogen Inc(BIIB) stock.
The initial trade took place in 2023Q2. And since then T. Rowe Price Mid Cap Growth Portfolio has made 5 purchases of BIIB, at an average price of $213.23, for a total of 98,044.00 shares. In addition, there have been 2 sales at an average price of $157.05 for 90,988.00 shares. Based on historical transaction data and BIIB's current price of $134.19, T. Rowe Price Mid Cap Growth Portfolio's estimated gain on his BIIB holdings is $-5.67 Mil, reflecting a -27.12% gain to date.
T. Rowe Price Mid Cap Growth Portfolio BIIB ($134.19) Holding Chart
T. Rowe Price Mid Cap Growth Portfolio BIIB ($134.19) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
